Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Antineoplastic Agents × Clear all

Status

Unknown 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Noonan Syndrome 5 1 Neoplasms 1 Liver Neoplasms 1 Immune-related Adverse Event 1 Esophageal Neoplasms 1 Early Hormone Receptor-positive Breast Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

pembrolizumab 35 Blood Specimen Collection 34 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 15 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Drug Therapy 11 Cisplatin 11 atezolizumab 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 10 Fluorouracil 9 Trastuzumab 8 Pemetrexed 8 Leucovorin 8 Cetuximab 8 pertuzumab 7 olaparib 7 Temozolomide 7 Oxaliplatin 7 Observation 7 Irinotecan 7 Interviews as Topic 7 Radiosurgery 6 Panitumumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡